AIkido Pharma is a biotechnology business based in the US. AIkido Pharma stocks (AIKI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.05 – a decrease of 3.23% over the previous week. AIkido Pharma employs 4 staff and has a trailing 12-month revenue of around $9,000.
How to buy stocks in AIkido Pharma
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AIKI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Finder's Pick for
Beginners

Finder's Pick for
Free Trades

Finder's Pick for
Commodity Stocks

Finder's Pick for
Global Trading

What's in this guide?
- Can I buy shares in AIkido Pharma?
- Has coronavirus impacted AIkido Pharma shares?
- AIkido Pharma shares summary
- Compare share dealing platforms
- Is AIkido Pharma stock a buy or sell?
- AIkido Pharma performance over time
- AIkido Pharma's financials
- How volatile are AIkido Pharma shares?
- Does AIkido Pharma pay a dividend?
- Have AIkido Pharma shares ever split?
- Other common questions
AIkido Pharma stock price (NASDAQ:AIKI)
Use our graph to track the performance of AIKI stocks over time.AIkido Pharma shares at a glance
Latest market close | $0.30 |
---|---|
52-week range | $0.29 - $1.21 |
50-day moving average | $0.38 |
200-day moving average | $0.61 |
Wall St. target price | $2.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.11 |
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy AIkido Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
AIkido Pharma price performance over time
Historical closes compared with the close of $0.3 from 2022-05-25
1 week (2022-05-20) | -3.23% |
---|---|
1 month (2022-04-27) | -6.25% |
3 months (2022-02-25) | -25.00% |
6 months (2021-11-26) | -58.90% |
1 year (2021-05-27) | -72.48% |
---|---|
2 years (2020-05-27) | -57.90% |
3 years (2019-05-24) | 3.0596 |
5 years (2017-05-26) | 0.9562 |
AIkido Pharma financials
Revenue TTM | $9,000 |
---|---|
Gross profit TTM | $9,000 |
Return on assets TTM | -6.13% |
Return on equity TTM | -6.09% |
Profit margin | 0% |
Book value | $1.06 |
Market capitalisation | $27.7 million |
TTM: trailing 12 months
AIkido Pharma share dividends
We're not expecting AIkido Pharma to pay a dividend over the next 12 months.
Have AIkido Pharma's shares ever split?
AIkido Pharma's shares were split on a 1113:1000 basis on 28 October 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1113 shares. This wouldn't directly have changed the overall worth of your AIkido Pharma shares – just the quantity. However, indirectly, the new 10.2% lower share price could have impacted the market appetite for AIkido Pharma shares which in turn could have impacted AIkido Pharma's share price.
AIkido Pharma share price volatility
Over the last 12 months, AIkido Pharma's shares have ranged in value from as little as $0.29 up to $1.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AIkido Pharma's is 1.5567. This would suggest that AIkido Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
AIkido Pharma overview
AIkido Pharma Inc. , a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc. , and Wake Forest University Health Sciences.
AIkido Pharma in the news
AIKIDO PHARMA INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

Former White House press secretary Jen Psaki will join MSNBC this fall
AIkido Pharma Announces Company Commitment to Board Diversity
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

Online gaming stocks
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
Read more…
Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
Read more…
Popular propane stocks to buy in Canada
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.
Read more…More guides on Finder
-
How to buy Bright Green Corporation stock in Canada
Steps to owning and managing BGXX stock, with 24-hour and historical pricing before you buy.
-
Apps like Wealthsimple
Learn more about apps like Wealthsimple to find the best trading platform for your unique set of needs.
-
Online gaming stocks
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
-
How to buy Entain stock in Canada
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
-
How to buy Kambi Group stock in Canada
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
-
Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
-
How to buy Rush Street Interactive stock in Canada
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
-
How to buy PointsBet stock in Canada
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
-
How to buy Hanover Bancorp stock in Canada
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
-
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.